CClinicalTrials.gg
CompletedNCT03296267Updated Jul 3, 2024

Influence of Bile Acids on Bacterial Uptake in Functional Dyspepsia

An interventional study of Gastroduodenoscopy in Functional Dyspepsia, sponsored by Universitaire Ziekenhuizen KU Leuven. Completed at 1 site in Belgium. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-03.

Sponsored by Universitaire Ziekenhuizen KU Leuven · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
18 Years to 60 Years
Sex
All
01

Study summary

In up to half of patients seen by gastroenterologists, routine examinations fail to find an underlying organic, systemic, or metabolic disease that readily explains the symptoms. These patients are referred to as patients with disorders of gastrointestinal function, of which functional dyspepsia (FD) is one of the most common. Despite intensive research to investigate various pathophysiological mechanisms of this disease, the pathogenesis remains obscure. The investigators recently demonstrated increased duodenal permeability in FD patients, as assessed by mounting routine endoscopic duodenal biopsy specimens into Ussing chambers to measure transepithelial electrical resistance and passage of a paracellular fluorescent probe. Impaired intestinal barrier function can lead to increased uptake of luminal substances which can induce an immunological response in the mucosa. Interestingly, using transmission electron microscopy (TEM) in duodenal biopsies, the investigators recently observed the presence of a yet to be identified microorganism inside the epithelium and the lamina propria of a subset of FD patients (unpublished observations), suggesting increased translocation of microorganisms.

The aim of the project is to investigate whether FD patients display increased translocation of microorganisms in duodenal biopsies. The investigators will also test the effect of bile acid on translocation of microorganisms and therefore include 20 FD patients and 20 age- and gender-matched healthy volunteers in this study.

Read the detailed description

The participants will be expected on the department endoscopy of the University Hospital Gasthuisberg, Leuven, Belgium. They are asked to fill in a bundle of questionnaires concerning physical complaints, depression, anxiety (disturbances), pain/disease, body/interoceptive awareness, trauma/abuse and personality. Endoscopy will be performed and up to 8 biopsies will be obtained from the duodenum. All endoscopies will be performed by an experienced endoscopist. Biopsies will be mounted in Ussing chambers and the mucosal compartment will be exposed to commercially available fluorescein-conjugated microorganisms. Uptake of microorganisms will be evaluated by analyzing the serosal compartment and by confocal microscopy of the biopsies. These experiments will also be performed in combination with exposure to bile acids separately and jointly, to assess if bacterial translocation can be exacerbated by these endogenous luminal factors individually and synergistically.

02

Conditions studied

  • Functional Dyspepsia

Browse trials for

Keywords

  • bile acid
  • bacterial uptake
03

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Three days before the measurement: no smoking and drinking alcohol
  • 12 hours before the measurement: no drinking and eating

Exclusion criteria

Exclusion Criteria:

  • symptoms or history of gastrointestinal disease
  • first degree relatives with celiac disease
  • diabetes mellitus
  • allergy/atopy (eczema, asthma, allergic rhinoconjunctivitis)
  • coagulation disorders/anticoagulant therapy
  • first degree relatives with Crohn's disease or type I diabetes mellitus.
  • intake of antihistamines, ketotifen, cromoglycate, acetylsalicylates, NSAIDs, anticholinergics, theophylline, β2-agonists, codeine or opioid derivatives for at least 2 weeks prior to the gastroscopy
  • Intake of steroid or immunosuppressive drugs in the last 6 months
04

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Enrollment
40 participants (actual)

Study arms

  • Other
    gastroduodenoscopy

    all participants undergo a gastroduodenoscopy to use the biopsies in an Ussing chamber experiment.

    Procedure: Gastroduodenoscopy

Interventions

  • ProcedureGastroduodenoscopy

    Gastroduodenoscopy with duodenal biospies: A tube is placed via the mouth into the second part of the duodenum. Biopsy forceps is used to take duodenal biopsies.

05

What researchers measure

Primary outcomes

  1. Bacterial uptake in the duodenal biopsy measured by fluorescent intensity at the basolateral side of the ussing chamber setup.

    duodenal uptake of fluorescein conjugated microorganisms

    Time frame: 120 minutes

Secondary outcomes

  1. duodenal permeability assessed by measuring transepithelial electrical resistance in the Ussing chamber setup

    transepithelial electrical resistance

    Time frame: 120 minutes

06

Study locations

1 site
  • Translational Research center for Gastrointestinal Disorders (TARGID)
    Leuven, Vlaams-Brabant 3000, Belgium
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03296267
Lead sponsor
Universitaire Ziekenhuizen KU Leuven
Responsible party
Sponsor
First posted
Sep 28, 2017
Start date
Jan 2, 2017
Primary completion
Apr 27, 2018
Completion
Aug 27, 2018
Last update
Jul 3, 2024

Study contacts

Jan Tack, Professor
principal investigator · KU Leuven

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion